Last reviewed · How we verify
NCT03666507
Vegetative Monitoring During Brainstem-associated Surgery
trial testing Intraoperative Monitoring during resection of brain tumor in Brain Tumor, Recurrent in 103 participants. Completed in 28 March 2021.
28 August 2020
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 103 |
| Start date | 28 August 2018 |
| Primary completion | 28 August 2020 |
| Estimated completion | 28 March 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Intraoperative Monitoring during resection of brain tumor
Conditions studied
- Brain Tumor, Recurrent — all drugs for Brain Tumor, Recurrent →
- Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
- Brainstem Neoplasm — all drugs for Brainstem Neoplasm →
- Brainstem Glioma — all drugs for Brainstem Glioma →
Sponsor
University Hospital Tuebingen
Who can join
Eligibility, any sex, with Brain Tumor, Recurrent or Vestibular Schwannoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intraoperative Monitoring of Heart rate variability, Blood pressure variability, Baroreceptorsensivity etc.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03666507
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brain Tumor, Recurrent
Currently open trials in the same condition.
- NCT06496971 — A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubbl · Phase 3 · recruiting
- NCT05634707 — Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) · EARLY_PHASE1 · active not recruiting
- NCT04427384 — Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) · recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03666507 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 4 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03666507.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing